1. Executive Summary
1.1. Global Peripheral Nerve Stimulators Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Peripheral Nerve Stimulators Market Outlook, 2018 - 2031
3.1. Global Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Transcutaneous
3.1.1.2. Implantable
3.2. Global Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Outpatient Center
3.2.1.3. Specialty Clinics
3.3. Global Peripheral Nerve Stimulators Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Peripheral Nerve Stimulators Market Outlook, 2018 - 2031
4.1. North America Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Transcutaneous
4.1.1.2. Implantable
4.2. North America Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Outpatient Center
4.2.1.3. Specialty Clinics
4.3. North America Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Peripheral Nerve Stimulators Market Outlook, 2018 - 2031
5.1. Europe Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Transcutaneous
5.1.1.2. Implantable
5.2. Europe Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Outpatient Center
5.2.1.3. Specialty Clinics
5.3. Europe Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Peripheral Nerve Stimulators Market Outlook, 2018 - 2031
6.1. Asia Pacific Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Transcutaneous
6.1.1.2. Implantable
6.2. Asia Pacific Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Outpatient Center
6.2.1.3. Specialty Clinics
6.3. Asia Pacific Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Peripheral Nerve Stimulators Market Outlook, 2018 - 2031
7.1. Latin America Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Transcutaneous
7.1.1.2. Implantable
7.2. Latin America Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Outpatient Center
7.2.1.3. Specialty Clinics
7.3. Latin America Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, 2018 - 2031
8.1. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Transcutaneous
8.1.1.2. Implantable
8.2. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Outpatient Center
8.2.1.3. Specialty Clinics
8.3. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.9. Nigeria Peripheral Nerve Stimulators Market End User, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
8.3.1.11. Rest of Middle East & Africa Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product Type vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Stimwave LLC.
9.5.1.1. Company Overview
9.5.1.2. Product Type Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. SUNMED INC.
9.5.2.1. Company Overview
9.5.2.2. Product Type Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Vygon SA
9.5.3.1. Company Overview
9.5.3.2. Product Type Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Boston Scientific Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Type Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Medline Industries, In
9.5.5.1. Company Overview
9.5.5.2. Product Type Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Enteromedics
9.5.6.1. Company Overview
9.5.6.2. Product Type Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. NeuroMetrix, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Type Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. SPR Therapeutics LLC
9.5.8.1. Company Overview
9.5.8.2. Product Type Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. ElectroCore, Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Type Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. NeuroSigma, Inc
9.5.10.1. Company Overview
9.5.10.2. Product Type Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations